3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Brain Neoplasms
41
Carcinoma, Non-Small-Cell Lung
35
Neoplasm Metastasis
32
Pancreatic Neoplasms
30
Prostatic Neoplasms
24
Lung Neoplasms
21
Carcinoma, Hepatocellular
21
Melanoma
16
Breast Neoplasms
12
Liver Neoplasms
10
Glioblastoma
10
Squamous Cell Carcinoma of Head and Neck
8
Carcinoma, Renal Cell
8
Neoplasms
7
Head and Neck Neoplasms
7
Kidney Neoplasms
6
Gliosarcoma
6
Sarcoma
5
Glioma
5
Central Nervous System Neoplasms
5
Uterine Cervical Neoplasms
4
Salivary Gland Neoplasms
4
Colorectal Neoplasms
4
Vulvar Neoplasms
3
Vaginal Neoplasms
3
Recurrence
3
Radiation Injuries
3
Pain
3
Ovarian Neoplasms
3
Fallopian Tube Neoplasms
3
Interventions
Morphine
11
Oxycodone
8
Fentanyl
6
nabiximols
5
Methadone
4
Hydromorphone
4
Acetaminophen
3
Transcutaneous Electric Nerve Stimulation
2
Tapentadol
2
Naloxone
2
Lidocaine
2
Buprenorphine
2
Acupuncture Therapy
2
tanezumab
1
resiniferatoxin
1
oxycodone naloxone combination
1
fulranumab
1
cannabichromene
1
alvimopan
1
Water
1
Ultracet
1
Transcranial Direct Current Stimulation
1
Tramadol
1
Therapeutic Touch
1
Telemedicine
1
Tablets
1
Surveys and Questionnaires
1
Sugars
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Cancer Pain
×
Radiosurgery
×
Clear all
NCT04595032
2024-11-07
MAMETIC
National Cancer Institute, Naples
Completed
3,234 enrolled